The concordance between the evolutionary trend and the clinical manifestation of the two SARS-CoV-2 variants

The spread of COVID-19, the disease caused by SARS-CoV-2, has progressed into a global pandemic. To date, thousands of genetic variants have been identified across strains of SARS-CoV-2 isolated from worldwide patients. However, there is still little direct evidence linking viral variants and clinical features. Based on two tightly linked SNPs, we previously divided SARS-CoV-2 into two major lineages: the ancestral “S lineage” (U8,782 and C28,144) and the derived “L lineage” (C8,782 and U28,144). Here, we identified SARS-CoV-2 lineages from 271 COVID-19 patients during the early outbreak of this pandemic in Wuhan, including 73 S- and 198 L-lineage patients. The S-lineage patients exhibited significantly worse clinical severity than the L-lineage patients, even after excluding other risk factors. This study suggests that SARS-CoV-2 lineage may provide useful clinical information for the management of COVID-19 and support the argument that viral clades should be analyzed as a function of clinical severity.

[1]  Weizhong Yang,et al.  Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study , 2021, The Lancet.

[2]  Songnian Hu,et al.  Evolutionary analysis and lineage designation of SARS-CoV-2 genomes , 2021, Science Bulletin.

[3]  Carl A. B. Pearson,et al.  Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England , 2021, Science.

[4]  D. A. Jackson,et al.  Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity , 2020, Cell.

[5]  Lanjuan Li,et al.  Patient-derived SARS-CoV-2 mutations impact viral replication dynamics and infectivity in vitro and with clinical implications in vivo , 2020, Cell discovery.

[6]  Edward C. Holmes,et al.  A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology , 2020, Nature Microbiology.

[7]  Yirong Wang,et al.  The use of SARS-CoV-2-related coronaviruses from bats and pangolins to polarize mutations in SARS-Cov-2 , 2020, Science China Life Sciences.

[8]  S. Rowland-Jones,et al.  Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus , 2020, Cell.

[9]  W. Wang,et al.  Viral and host factors related to the clinical outcome of COVID-19 , 2020, Nature.

[10]  Colin Renfrew,et al.  Phylogenetic network analysis of SARS-CoV-2 genomes , 2020, Proceedings of the National Academy of Sciences.

[11]  Xiang Li,et al.  On the origin and continuing evolution of SARS-CoV-2 , 2020, National science review.

[12]  Yan Zhao,et al.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, JAMA.

[13]  E. Holmes,et al.  A new coronavirus associated with human respiratory disease in China , 2020, Nature.

[14]  M. Franzblau,et al.  Conflict of Interest Statement , 2004 .